This is a critical moment in the field of lung cancer. New strategies for multidisciplinary approaches are becoming more important; pharmacogenomic research and clinical trials including genetic assessment are advancing at a great pace. In order to keep abreast of the latest developments in basic, clinical and translational research, the 2nd European Lung Cancer Conference is THE thoracic CME conference to attend.

The event will be held at the Geneva Palexpo, which is located 10 minutes from the city center, within walking distance from Geneva International Airport and easily reachable by car and train.

Geneva Palexpo
1218 Grand-Saconnex
Geneva, Switzerland
www.geneva-palexpo.ch

Click here to see the map

Abstract submission	18 January 2010
Early registration	24 February 2010
Late registration	24 March 2010

The official language of the Conference is English. Sessions will not be translated.

More than 1500 specialists in lung cancer are expected to join this program.